Trials / Completed
CompletedNCT04949074
Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19
Collection of SARS-CoV-2 RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- ID Solutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Constitution of a collection of SARS-CoV-2 RNA extracts from nasopharyngeal and saliva / sputum samples, from the same patients (paired samples), taken during the same consultation in an indication of detection of SARS-CoV-2 in with a view to developing tests / diagnostic tools for SARS-CoV-2.
Detailed description
In order to preserve their anonymity, the participant will be identified in a dedicated form by a unique identification number. An identification list of participants will be kept in the investigator's file. The investigator will ensure that the anonymity of each person participating in the research is guaranteed. The source documents are the original documents, data and files from which the data concerning the participant is reported in the Data set\_COLL001.xls form provided to the investigator which will serve as an observation notebook. The investigator must agree to allow direct access to research source data during monitoring, audit or inspection visits. The source data is for the most part computerized and accessible after authorization. The data will be transcribed into an Excel form Data set\_COLL001.xls pseudonymized form which will serve as an observation book. The data will be recorded and then transmitted to ID SOLUTIONS via the Data set\_COLL001.xls form provided to the investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | saliva sampling | when the patient goes to the laboratory for a covid 19 diagnostic from a routine nasopharingeal sample, an additionnal sample of saliva is asked |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
- First posted
- 2021-07-02
- Last updated
- 2023-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04949074. Inclusion in this directory is not an endorsement.